Tessier F, Quentin C
Laboratoire de Microbiologie, UFR des Sciences Pharmaceutiques, Université de Bordeaux II, France.
Eur J Clin Microbiol Infect Dis. 1997 Feb;16(2):159-62. doi: 10.1007/BF01709477.
The in vitro activity of fosfomycin in combination with ceftazidime, imipenem, amikacin, or ciprofloxacin was studied by an agar plate checkerboard method against 40 clinical isolates of Pseudomonas aeruginosa with various antibiotic resistance profiles. Fosfomycin/ciprofloxacin appeared to be the most effective combination (synergy 15%, addition 80%, indifference 5%), followed by fosfomycin/amikacin (synergy 7.5%, addition 52.5%, indifference 40%), fosfomycin/imipenem (addition 37%, indifference 63%), and fosfomycin/ceftazidime (addition 20%, indifference 80%). The effects of the combinations were not significantly influenced by the antibiotic susceptibility patterns of the strains.
采用琼脂平板棋盘法,研究了磷霉素与头孢他啶、亚胺培南、阿米卡星或环丙沙星联合应用对40株具有不同抗生素耐药谱的铜绿假单胞菌临床分离株的体外活性。磷霉素/环丙沙星似乎是最有效的联合用药方案(协同作用15%,相加作用80%,无关作用5%),其次是磷霉素/阿米卡星(协同作用7.5%,相加作用52.5%,无关作用40%)、磷霉素/亚胺培南(相加作用37%,无关作用63%)和磷霉素/头孢他啶(相加作用20%,无关作用80%)。联合用药的效果不受菌株抗生素敏感性模式的显著影响。